Click for best price
Therapeutic Vaccines Market Size, Share 2024
| Market size in 2023 |
US$ 31940 million
|
Forecast Market size by 2029 |
US$ 112360 million
|
| Growth Rate |
CAGR of 19.7% |
Number of Pages |
72 Pages |
This report aims to provide a comprehensive presentation of the global market for Therapeutic Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Vaccines. This report contains market size and forecasts of Therapeutic Vaccines in global, including the following market information:
Global Therapeutic Vaccines Market Revenue, 2019-2024, 2024-2029, ($ millions)
Global Therapeutic Vaccines Market Sales, 2019-2024, 2024-2029, (K Units)
Global top five Therapeutic Vaccines companies in 2023 (%)
The global Therapeutic Vaccines market was valued at US$ 31940 million in 2023 and is projected to reach US$ 112360 million by 2029, at a CAGR of 19.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Peptide Therapeutic Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Vaccines include Northeast Biotherapeutics, Agenus, Vaccinogen Inc, CIMAB S.A, Dendreon, Corixa and AVAX Technologies, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Therapeutic Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Vaccines Market, by Type, 2019-2024, 2024-2029 ($ Millions) & (K Units)
Global Therapeutic Vaccines Market Segment Percentages, by Type, 2023 (%)
Peptide Therapeutic Vaccine
Cell Therapeutic Vaccine
Nucleic Acid Therapeutic Vaccine
Global Therapeutic Vaccines Market, by Application, 2019-2024, 2024-2029 ($ Millions) & (K Units)
Global Therapeutic Vaccines Market Segment Percentages, by Application, 2023 (%)
Oncotherapy
Hepatitis B
Tuberculosis
Herpes Simplex Virus
Others
Global Therapeutic Vaccines Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions) & (K Units)
Global Therapeutic Vaccines Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Vaccines revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Therapeutic Vaccines revenues share in global market, 2023 (%)
Key companies Therapeutic Vaccines sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Therapeutic Vaccines sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Northeast Biotherapeutics
Agenus
Vaccinogen Inc
CIMAB S.A
Dendreon
Corixa
AVAX Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Therapeutic Vaccines, market overview.
Chapter 2: Global Therapeutic Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Therapeutic Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Therapeutic Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Therapeutic Vaccines Market, Global Outlook and Forecast 2024-2031 |
| Market size in 2023 |
US$ 31940 million
|
| Forecast Market size by 2029 |
US$ 112360 million
|
| Growth Rate |
CAGR of 19.7% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Therapeutic Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Therapeutic Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Therapeutic Vaccines Overall Market Size
2.1 Global Therapeutic Vaccines Market Size: 2022 VS 2031
2.2 Global Therapeutic Vaccines Revenue, Prospects & Forecasts: 2019-2031
2.3 Global Therapeutic Vaccines Sales: 2019-2031
3 Company Landscape
3.1 Top Therapeutic Vaccines Players in Global Market
3.2 Top Global Therapeutic Vaccines Companies Ranked by Revenue
3.3 Global Therapeutic Vaccines Revenue by Companies
3.4 Global Therapeutic Vaccines Sales by Companies
3.5 Global Therapeutic Vaccines Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Therapeutic Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Therapeutic Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Therapeutic Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Therapeutic Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Therapeutic Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Therapeutic Vaccines Market Size Markets, 2022 & 2031
4.1.2 Peptide Therapeutic Vaccine
4.1.3 Cell Therapeutic Vaccine
4.1.4 Nucleic Acid Therapeutic Vaccine
4.2 By Type - Global Therapeutic Vaccines Revenue & Forecasts
4.2.1 By Type - Global Therapeutic Vaccines Revenue, 2019-2024
4.2.2 By Type - Global Therapeutic Vaccines Revenue, 2024-2031
4.2.3 By Type - Global Therapeutic Vaccines Revenue Market Share, 2019-2031
4.3 By Type - Global Therapeutic Vaccines Sales & Forecasts
4.3.1 By Type - Global Therapeutic Vaccines Sales, 2019-2024
4.3.2 By Type - Global Therapeutic Vaccines Sales, 2024-2031
4.3.3 By Type - Global Therapeutic Vaccines Sales Market Share, 2019-2031
4.4 By Type - Global Therapeutic Vaccines Price (Manufacturers Selling Prices), 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Therapeutic Vaccines Market Size, 2022 & 2031
5.1.2 Oncotherapy
5.1.3 Hepatitis B
5.1.4 Tuberculosis
5.1.5 Herpes Simplex Virus
5.1.6 Others
5.2 By Application - Global Therapeutic Vaccines Revenue & Forecasts
5.2.1 By Application - Global Therapeutic Vaccines Revenue, 2019-2024
5.2.2 By Application - Global Therapeutic Vaccines Revenue, 2024-2031
5.2.3 By Application - Global Therapeutic Vaccines Revenue Market Share, 2019-2031
5.3 By Application - Global Therapeutic Vaccines Sales & Forecasts
5.3.1 By Application - Global Therapeutic Vaccines Sales, 2019-2024
5.3.2 By Application - Global Therapeutic Vaccines Sales, 2024-2031
5.3.3 By Application - Global Therapeutic Vaccines Sales Market Share, 2019-2031
5.4 By Application - Global Therapeutic Vaccines Price (Manufacturers Selling Prices), 2019-2031
6 Sights by Region
6.1 By Region - Global Therapeutic Vaccines Market Size, 2022 & 2031
6.2 By Region - Global Therapeutic Vaccines Revenue & Forecasts
6.2.1 By Region - Global Therapeutic Vaccines Revenue, 2019-2024
6.2.2 By Region - Global Therapeutic Vaccines Revenue, 2024-2031
6.2.3 By Region - Global Therapeutic Vaccines Revenue Market Share, 2019-2031
6.3 By Region - Global Therapeutic Vaccines Sales & Forecasts
6.3.1 By Region - Global Therapeutic Vaccines Sales, 2019-2024
6.3.2 By Region - Global Therapeutic Vaccines Sales, 2024-2031
6.3.3 By Region - Global Therapeutic Vaccines Sales Market Share, 2019-2031
6.4 North America
6.4.1 By Country - North America Therapeutic Vaccines Revenue, 2019-2031
6.4.2 By Country - North America Therapeutic Vaccines Sales, 2019-2031
6.4.3 US Therapeutic Vaccines Market Size, 2019-2031
6.4.4 Canada Therapeutic Vaccines Market Size, 2019-2031
6.4.5 Mexico Therapeutic Vaccines Market Size, 2019-2031
6.5 Europe
6.5.1 By Country - Europe Therapeutic Vaccines Revenue, 2019-2031
6.5.2 By Country - Europe Therapeutic Vaccines Sales, 2019-2031
6.5.3 Germany Therapeutic Vaccines Market Size, 2019-2031
6.5.4 France Therapeutic Vaccines Market Size, 2019-2031
6.5.5 U.K. Therapeutic Vaccines Market Size, 2019-2031
6.5.6 Italy Therapeutic Vaccines Market Size, 2019-2031
6.5.7 Russia Therapeutic Vaccines Market Size, 2019-2031
6.5.8 Nordic Countries Therapeutic Vaccines Market Size, 2019-2031
6.5.9 Benelux Therapeutic Vaccines Market Size, 2019-2031
6.6 Asia
6.6.1 By Region - Asia Therapeutic Vaccines Revenue, 2019-2031
6.6.2 By Region - Asia Therapeutic Vaccines Sales, 2019-2031
6.6.3 China Therapeutic Vaccines Market Size, 2019-2031
6.6.4 Japan Therapeutic Vaccines Market Size, 2019-2031
6.6.5 South Korea Therapeutic Vaccines Market Size, 2019-2031
6.6.6 Southeast Asia Therapeutic Vaccines Market Size, 2019-2031
6.6.7 India Therapeutic Vaccines Market Size, 2019-2031
6.7 South America
6.7.1 By Country - South America Therapeutic Vaccines Revenue, 2019-2031
6.7.2 By Country - South America Therapeutic Vaccines Sales, 2019-2031
6.7.3 Brazil Therapeutic Vaccines Market Size, 2019-2031
6.7.4 Argentina Therapeutic Vaccines Market Size, 2019-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Therapeutic Vaccines Revenue, 2019-2031
6.8.2 By Country - Middle East & Africa Therapeutic Vaccines Sales, 2019-2031
6.8.3 Turkey Therapeutic Vaccines Market Size, 2019-2031
6.8.4 Israel Therapeutic Vaccines Market Size, 2019-2031
6.8.5 Saudi Arabia Therapeutic Vaccines Market Size, 2019-2031
6.8.6 UAE Therapeutic Vaccines Market Size, 2019-2031
7 Manufacturers & Brands Profiles
7.1 Northeast Biotherapeutics
7.1.1 Northeast Biotherapeutics Company Summary
7.1.2 Northeast Biotherapeutics Business Overview
7.1.3 Northeast Biotherapeutics Therapeutic Vaccines Major Product Offerings
7.1.4 Northeast Biotherapeutics Therapeutic Vaccines Sales and Revenue in Global (2019-2024)
7.1.5 Northeast Biotherapeutics Key News & Latest Developments
7.2 Agenus
7.2.1 Agenus Company Summary
7.2.2 Agenus Business Overview
7.2.3 Agenus Therapeutic Vaccines Major Product Offerings
7.2.4 Agenus Therapeutic Vaccines Sales and Revenue in Global (2019-2024)
7.2.5 Agenus Key News & Latest Developments
7.3 Vaccinogen Inc
7.3.1 Vaccinogen Inc Company Summary
7.3.2 Vaccinogen Inc Business Overview
7.3.3 Vaccinogen Inc Therapeutic Vaccines Major Product Offerings
7.3.4 Vaccinogen Inc Therapeutic Vaccines Sales and Revenue in Global (2019-2024)
7.3.5 Vaccinogen Inc Key News & Latest Developments
7.4 CIMAB S.A
7.4.1 CIMAB S.A Company Summary
7.4.2 CIMAB S.A Business Overview
7.4.3 CIMAB S.A Therapeutic Vaccines Major Product Offerings
7.4.4 CIMAB S.A Therapeutic Vaccines Sales and Revenue in Global (2019-2024)
7.4.5 CIMAB S.A Key News & Latest Developments
7.5 Dendreon
7.5.1 Dendreon Company Summary
7.5.2 Dendreon Business Overview
7.5.3 Dendreon Therapeutic Vaccines Major Product Offerings
7.5.4 Dendreon Therapeutic Vaccines Sales and Revenue in Global (2019-2024)
7.5.5 Dendreon Key News & Latest Developments
7.6 Corixa
7.6.1 Corixa Company Summary
7.6.2 Corixa Business Overview
7.6.3 Corixa Therapeutic Vaccines Major Product Offerings
7.6.4 Corixa Therapeutic Vaccines Sales and Revenue in Global (2019-2024)
7.6.5 Corixa Key News & Latest Developments
7.7 AVAX Technologies
7.7.1 AVAX Technologies Company Summary
7.7.2 AVAX Technologies Business Overview
7.7.3 AVAX Technologies Therapeutic Vaccines Major Product Offerings
7.7.4 AVAX Technologies Therapeutic Vaccines Sales and Revenue in Global (2019-2024)
7.7.5 AVAX Technologies Key News & Latest Developments
8 Global Therapeutic Vaccines Production Capacity, Analysis
8.1 Global Therapeutic Vaccines Production Capacity, 2019-2031
8.2 Therapeutic Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Therapeutic Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Therapeutic Vaccines Supply Chain Analysis
10.1 Therapeutic Vaccines Industry Value Chain
10.2 Therapeutic Vaccines Upstream Market
10.3 Therapeutic Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Therapeutic Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Therapeutic Vaccines in Global Market
Table 2. Top Therapeutic Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Therapeutic Vaccines Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Therapeutic Vaccines Revenue Share by Companies, 2019-2024
Table 5. Global Therapeutic Vaccines Sales by Companies, (K Units), 2019-2024
Table 6. Global Therapeutic Vaccines Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Therapeutic Vaccines Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Therapeutic Vaccines Product Type
Table 9. List of Global Tier 1 Therapeutic Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Therapeutic Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Therapeutic Vaccines Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Global Therapeutic Vaccines Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Therapeutic Vaccines Revenue (US$, Mn), 2024-2031
Table 14. By Type - Global Therapeutic Vaccines Sales (K Units), 2019-2024
Table 15. By Type - Global Therapeutic Vaccines Sales (K Units), 2024-2031
Table 16. By Application ? Global Therapeutic Vaccines Revenue, (US$, Mn), 2022 & 2031
Table 17. By Application - Global Therapeutic Vaccines Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Therapeutic Vaccines Revenue (US$, Mn), 2024-2031
Table 19. By Application - Global Therapeutic Vaccines Sales (K Units), 2019-2024
Table 20. By Application - Global Therapeutic Vaccines Sales (K Units), 2024-2031
Table 21. By Region ? Global Therapeutic Vaccines Revenue, (US$, Mn), 2022 VS 2031
Table 22. By Region - Global Therapeutic Vaccines Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Therapeutic Vaccines Revenue (US$, Mn), 2024-2031
Table 24. By Region - Global Therapeutic Vaccines Sales (K Units), 2019-2024
Table 25. By Region - Global Therapeutic Vaccines Sales (K Units), 2024-2031
Table 26. By Country - North America Therapeutic Vaccines Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Therapeutic Vaccines Revenue, (US$, Mn), 2024-2031
Table 28. By Country - North America Therapeutic Vaccines Sales, (K Units), 2019-2024
Table 29. By Country - North America Therapeutic Vaccines Sales, (K Units), 2024-2031
Table 30. By Country - Europe Therapeutic Vaccines Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Therapeutic Vaccines Revenue, (US$, Mn), 2024-2031
Table 32. By Country - Europe Therapeutic Vaccines Sales, (K Units), 2019-2024
Table 33. By Country - Europe Therapeutic Vaccines Sales, (K Units), 2024-2031
Table 34. By Region - Asia Therapeutic Vaccines Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Therapeutic Vaccines Revenue, (US$, Mn), 2024-2031
Table 36. By Region - Asia Therapeutic Vaccines Sales, (K Units), 2019-2024
Table 37. By Region - Asia Therapeutic Vaccines Sales, (K Units), 2024-2031
Table 38. By Country - South America Therapeutic Vaccines Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Therapeutic Vaccines Revenue, (US$, Mn), 2024-2031
Table 40. By Country - South America Therapeutic Vaccines Sales, (K Units), 2019-2024
Table 41. By Country - South America Therapeutic Vaccines Sales, (K Units), 2024-2031
Table 42. By Country - Middle East & Africa Therapeutic Vaccines Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Therapeutic Vaccines Revenue, (US$, Mn), 2024-2031
Table 44. By Country - Middle East & Africa Therapeutic Vaccines Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Therapeutic Vaccines Sales, (K Units), 2024-2031
Table 46. Northeast Biotherapeutics Company Summary
Table 47. Northeast Biotherapeutics Therapeutic Vaccines Product Offerings
Table 48. Northeast Biotherapeutics Therapeutic Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Northeast Biotherapeutics Key News & Latest Developments
Table 50. Agenus Company Summary
Table 51. Agenus Therapeutic Vaccines Product Offerings
Table 52. Agenus Therapeutic Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Agenus Key News & Latest Developments
Table 54. Vaccinogen Inc Company Summary
Table 55. Vaccinogen Inc Therapeutic Vaccines Product Offerings
Table 56. Vaccinogen Inc Therapeutic Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Vaccinogen Inc Key News & Latest Developments
Table 58. CIMAB S.A Company Summary
Table 59. CIMAB S.A Therapeutic Vaccines Product Offerings
Table 60. CIMAB S.A Therapeutic Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. CIMAB S.A Key News & Latest Developments
Table 62. Dendreon Company Summary
Table 63. Dendreon Therapeutic Vaccines Product Offerings
Table 64. Dendreon Therapeutic Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Dendreon Key News & Latest Developments
Table 66. Corixa Company Summary
Table 67. Corixa Therapeutic Vaccines Product Offerings
Table 68. Corixa Therapeutic Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Corixa Key News & Latest Developments
Table 70. AVAX Technologies Company Summary
Table 71. AVAX Technologies Therapeutic Vaccines Product Offerings
Table 72. AVAX Technologies Therapeutic Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. AVAX Technologies Key News & Latest Developments
Table 74. Therapeutic Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 75. Global Therapeutic Vaccines Capacity Market Share of Key Manufacturers, 2021-2024
Table 76. Global Therapeutic Vaccines Production by Region, 2019-2024 (K Units)
Table 77. Global Therapeutic Vaccines Production by Region, 2024-2031 (K Units)
Table 78. Therapeutic Vaccines Market Opportunities & Trends in Global Market
Table 79. Therapeutic Vaccines Market Drivers in Global Market
Table 80. Therapeutic Vaccines Market Restraints in Global Market
Table 81. Therapeutic Vaccines Raw Materials
Table 82. Therapeutic Vaccines Raw Materials Suppliers in Global Market
Table 83. Typical Therapeutic Vaccines Downstream
Table 84. Therapeutic Vaccines Downstream Clients in Global Market
Table 85. Therapeutic Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Therapeutic Vaccines Segment by Type in 2022
Figure 2. Therapeutic Vaccines Segment by Application in 2022
Figure 3. Global Therapeutic Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Therapeutic Vaccines Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Therapeutic Vaccines Revenue, 2019-2031 (US$, Mn)
Figure 7. Therapeutic Vaccines Sales in Global Market: 2019-2031 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Therapeutic Vaccines Revenue in 2022
Figure 9. By Type - Global Therapeutic Vaccines Revenue, (US$, Mn), 2022 & 2031
Figure 10. By Type - Global Therapeutic Vaccines Revenue Market Share, 2019-2031
Figure 11. By Type - Global Therapeutic Vaccines Sales Market Share, 2019-2031
Figure 12. By Type - Global Therapeutic Vaccines Price (USD/Unit), 2019-2031
Figure 13. By Application - Global Therapeutic Vaccines Revenue, (US$, Mn), 2022 & 2031
Figure 14. By Application - Global Therapeutic Vaccines Revenue Market Share, 2019-2031
Figure 15. By Application - Global Therapeutic Vaccines Sales Market Share, 2019-2031
Figure 16. By Application - Global Therapeutic Vaccines Price (USD/Unit), 2019-2031
Figure 17. By Region - Global Therapeutic Vaccines Revenue, (US$, Mn), 2022 & 2031
Figure 18. By Region - Global Therapeutic Vaccines Revenue Market Share, 2019 VS 2022 VS 2031
Figure 19. By Region - Global Therapeutic Vaccines Revenue Market Share, 2019-2031
Figure 20. By Region - Global Therapeutic Vaccines Sales Market Share, 2019-2031
Figure 21. By Country - North America Therapeutic Vaccines Revenue Market Share, 2019-2031
Figure 22. By Country - North America Therapeutic Vaccines Sales Market Share, 2019-2031
Figure 23. US Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 24. Canada Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 25. Mexico Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 26. By Country - Europe Therapeutic Vaccines Revenue Market Share, 2019-2031
Figure 27. By Country - Europe Therapeutic Vaccines Sales Market Share, 2019-2031
Figure 28. Germany Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 29. France Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 30. U.K. Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 31. Italy Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 32. Russia Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 33. Nordic Countries Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 34. Benelux Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 35. By Region - Asia Therapeutic Vaccines Revenue Market Share, 2019-2031
Figure 36. By Region - Asia Therapeutic Vaccines Sales Market Share, 2019-2031
Figure 37. China Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 38. Japan Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 39. South Korea Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 40. Southeast Asia Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 41. India Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 42. By Country - South America Therapeutic Vaccines Revenue Market Share, 2019-2031
Figure 43. By Country - South America Therapeutic Vaccines Sales Market Share, 2019-2031
Figure 44. Brazil Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 45. Argentina Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 46. By Country - Middle East & Africa Therapeutic Vaccines Revenue Market Share, 2019-2031
Figure 47. By Country - Middle East & Africa Therapeutic Vaccines Sales Market Share, 2019-2031
Figure 48. Turkey Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 49. Israel Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 50. Saudi Arabia Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 51. UAE Therapeutic Vaccines Revenue, (US$, Mn), 2019-2031
Figure 52. Global Therapeutic Vaccines Production Capacity (K Units), 2019-2031
Figure 53. The Percentage of Production Therapeutic Vaccines by Region, 2022 VS 2031
Figure 54. Therapeutic Vaccines Industry Value Chain
Figure 55. Marketing Channels
